Polyvalent Immunoglobulin in COVID-19 Related ARds (ICAR)

Clinical Trial ID NCT04350580

PubWeight™ 0.00‹?›

🔗 Visit the ClinicalTrials.gov page for NCT04350580

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020 18.32
2 Intravenous immunoglobulin for treating sepsis, severe sepsis and septic shock. Cochrane Database Syst Rev 2013 1.70
3 Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med 2020 1.38
4 Intravenous immunoglobulin for the treatment of Kawasaki disease in children. Cochrane Database Syst Rev 2003 1.31
5 Lymphocytic interstitial pneumonia associated with common variable immunodeficiency resolved with intravenous immunoglobulins. Thorax 2006 0.83
6 Mechanisms of action of intravenous immunoglobulin. Transfus Apher Sci 2016 0.75
Next 100